Oh dear, I believe the DurAVR and ADAPT technology is an advance, the company is showing a stellar performance and the presentation was excellent. But, investors unaware of the different procedures and the reasons for choosing one over another, or the characteristics, technology and performance of competitors products could easily believe that the product is far further advanced than their competitors than they really are. As an aorta valve recipient I have an interest and possibly a little more knowledge than the average investor. The stock is certainly on my watch list and I await an entry point.
Oh dear, I believe the DurAVR and ADAPT technology is an...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |